Navigation Links
PharmAthene Reports Third Quarter 2013 Financial And Operational Results
Date:11/7/2013

matters related thereto; failure of either party to meet the conditions to closing of the transaction; delays in completing the transaction and the risk that the transaction may not be completed at all; failure to realize the anticipated benefits from the transaction or delay in realization thereof; the businesses of PharmAthene and Theraclone may not be combined successfully, or such combination may take longer, be more difficult, time-consuming or costly to accomplish than expected; operating costs and business disruption during the pendency of and following the transaction, including adverse effects on employee retention and on business relationships with third parties; the combined company's need for and ability to obtain additional financing; risk associated with the reliability of the results of the studies relating to human safety and possible adverse effects resulting from the administration of the combined company's product candidates; unexpected funding delays and/or reductions or elimination of U.S. government funding for one or more of the combined company's development programs; the award of government contracts to competitors; unforeseen safety issues; unexpected determinations that these product candidates prove not to be effective or capable of being marketed as products; as well as risks detailed from time to time in PharmAthene's annual report on Form 10-K and quarterly reports on Form 10-Q under the caption "Risk Factors" and in its other reports filed with the SEC. Copies of PharmAthene's public disclosure filings are available from its investor relations department and our website under the investor relations tab at www.PharmAthene.com.

-- Tables Follow –PHARMATHENE, INC.CONDENSED CONSOLIDATED BALANCE SHEETSSeptember 30,December 31,20132012 (Unaudited) ASSETSCurrent assets:Cash and cash equivalents

$
5,943,399$
2,701,517Billed accounts receivable

-2,432,641
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. PharmAthene to Present at Rodman & Renshaw Annual Global Investment Conference
2. PharmAthene and Theraclone Sciences Announce Merger Agreement to Create Diversified Biologics Company Targeting Government and Commercial Markets
3. PharmAthene Reports First Quarter 2013 Financial And Operational Results
4. New Data Show PharmAthenes Recombinant Bioscavenger Binds To A Broad Spectrum Of Chemical Nerve Agents
5. SIGA Technologies Files Notice of Appeal in PharmAthene Litigation
6. Pharmacyclics Reports Third Quarter 2013 Results
7. CareFusion Reports First Quarter Fiscal 2014 Results
8. Sequenom, Inc. Reports Financial Results For The Third Quarter Of 2013
9. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results
10. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
11. ANI Pharmaceuticals Reports Net Revenues of $7.8 million, adjusted Non-GAAP EBITDA of $1.7 Million, and EPS of $0.13 for the Third Quarter Ended September 30, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)...  Mytrus, a technology and services company revolutionizing clinical trials, announced ... has received approval for use by Britain,s ... first time e-Consent technology will be used in a ... Mytrus was also the first electronic informed consent ... the U.S. Food and Drug Administration in 2011. It ...
(Date:8/27/2015)... CAESAREA, Israel , August 27, 2015 ... Equity today announced a private investment in public equity ... up to $28.4 million in Itamar Medical.   ... the largest shareholder of Itamar Medical and will work ... market expansion. According to the investment agreement, ...
(Date:8/27/2015)... 27, 2015 The Elekta Linac-based ... Boston on July 9th for its ... to more fully exploit the potential of advances in ... diseases. "As an established provider of sophisticated ... assume a leadership role - in collaboration with its ...
Breaking Medicine Technology:Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 2Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 3Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 4Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 5Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 6Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 7Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 2Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 3Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 4Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 5New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 3
(Date:8/28/2015)... ... August 28, 2015 , ... On October 3, 2015, BethAnn Telford of TeamBT and ... Grand Canyon with a shared mission: to beat brain cancer. In one grueling day, ... canyon, then up to the South Rim over 21.1 miles and more than 10,000 feet ...
(Date:8/27/2015)... ... August 28, 2015 , ... Grace Bay Beach has ... is added to an already impressive list of accolades for the Turks and Caicos ... the #2 beach in the world by TripAdvisor, the world's leading authority on travel. ...
(Date:8/27/2015)... Los Angeles, CA (PRWEB) , ... August 27, 2015 , ... ... suggests that the helpfulness of a doctor is tied directly to the success of ... obese patients over a two year period, measured their weight loss over that period, ...
(Date:8/27/2015)... , ... August 27, 2015 , ... ... average annual cost to treat a patient with hemophilia is $175,000. Hemophilia is ... a cure and improving treatment. The RMHBDA exists to help raise funds for ...
(Date:8/27/2015)... Angeles, CA (PRWEB) , ... August 27, 2015 , ... ... Association and the American Heart Association have released new guidelines to educate doctors and ... the last update to these particular guidelines came in 2007, so the new version ...
Breaking Medicine News(10 mins):Health News:Women Athletes Cross the Grand Canyon to Raise Funds for Brain Cancer Research – October 3rd 2Health News:Grace Bay Beach Acknowledged as a Top Caribbean Beach for Weddings 2Health News:Article on Physician Influence on Weight Loss Highlights the Importance of a Doctor Who Cares, says Dr. Feiz & Associates 2Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 2Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 3Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 4Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 2Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 3
... meets an HIV-positive patient, one of her first questions is ... The usual response is about dead relatives or friends. "We ... likelihood, his experience will be very different," said the infectious-disease ... Sciences University. "Yes it,s the same virus and could have ...
... HealthDay Reporter , TUESDAY, March 6 (HealthDay News) -- ... especially post-traumatic stress disorder, are more likely than mentally ... study finds. Use of these opioid pain medications, ... and cause more serious problems, researchers say. "Veterans ...
... , TUESDAY, March 6 (HealthDay News) -- ... preterm deliveries and underweight babies, a new study finds. ... in March 2006. The researchers analyzed data on preterm delivery ... The number of mothers who smoked dropped from more ...
... likely than Caucasians to develop an excessive growth of thick, ... as a keloid following head and neck surgery, according ... This finding, however, is much lower than that previously ... been shown to be up to 16 percent in African ...
... University,s Marcel Just provides an explanation for some of ... restricted interests and gives scientists clear targets for ... been a scientific enigma, mainly due to its diverse ... the journal Neuroscience and Biobehavioral Reviews , Just ...
... The Center for Public-Private Partnerships at The Henry M. ... is pleased to announce the recipients of the 2012 ... themselves through excellence and selfless dedication to advancing medicine ... veterans and their families. The recipients will be honored ...
Cached Medicine News:Health News:Federal grant enables HIV testing, treatment in the Augusta area 2Health News:Federal grant enables HIV testing, treatment in the Augusta area 3Health News:Narcotic Painkillers Another Threat to Traumatized War Vets: Study 2Health News:Narcotic Painkillers Another Threat to Traumatized War Vets: Study 3Health News:African-Americans 7 times more likely to have keloid scarring of the head, neck 2Health News:New brain imaging and computer modeling predicts autistic brain activity and behavior 2Health News:New brain imaging and computer modeling predicts autistic brain activity and behavior 3Health News:HJF Center announces Heroes of Military Medicine award recipients 2
... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...
... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...
... Durable ergonomic chairs with concave ... support • Select options like seats, ... • Choose the BE Series for ... environments including: industry, education, laboratory, clean ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... the BE Series for top performance ... industry, education, laboratory, clean room, static ...
Medicine Products: